Summary
- Current Price
- As of today, QGEN price is $40.60, down -1.26% on
- Current Price All-Time High
- QGEN price is currently -35.31% below its historical high of $62.76 set on
- Market Cap
- QGEN current market cap is $8B, up +4.72% over the past 365 days
- PE Ratio
- QGEN current PE ratio is 19.86
- Revenue
- QGEN current annual revenue is $2.09B, up +5.65% year-over-year
- Next Earnings
- The next earnings release for QGEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Qiagen N.V. |
| Ticker | NYSE: QGEN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | Netherlands |
| IPO | |
| Indexes | Not included |
| Website | qiagen.com |
| Employees | 5,700 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $40.60 | |
| Price, 1D Change | -1.26% | |
| Market Cap | $8B | |
| TTM Dividend Yield | 6.26% | |
| PE Ratio | 19.86 | |
| Beta | 0.48 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +5.65% | |
| EPS | $2.04 | |
| EPS, 1Y Change | +407.40% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.29 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 19:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.04 | |
| EPS Estimate | N/A | $2.51 |
| EPS Est. Change | N/A | +22.86% |
| Revenue | $2.09B | |
| Revenue Estimate | N/A | $2.22B |
| Revenue Est. Change | N/A | +6.03% |
| Current Price | $40.60 | |
| Price Target | - | $54.00 |
| Price Tgt. Change | - | +33.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.24 | $0.40 | -82.00% | |
| $2.48 | $2.04 | -17.64% | |
| $2.51 | N/A | +22.86% | |
| $2.76 | N/A | +35.29% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.98B | $1.98B | -0.06% | |
| $2.08B | $2.09B | +0.62% | |
| $2.22B | N/A | +6.03% | |
| $2.35B | N/A | +12.27% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +4.37% | |
| Price, 3Y | -15.25% | |
| Market Cap, 1Y | +4.72% | |
| Market Cap, 3Y | -14.42% | |
| Revenue, 1Y | +5.65% | |
| Revenue, 3Y | -2.41% | |
| EPS, 1Y | +407.40% | |
| EPS, 3Y | +7.78% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $40.60 | |
| SMA 200 | $47.48 | |
| SMA 200 vs Price | +16.95% | |
| SMA 50 | $49.00 | |
| SMA 50 vs Price | +20.70% | |
| Beta | 0.48 | |
| ATR | $1.38 | |
| 14-Day RSI | 19.54 | |
| 10-Day Volatility | 21.30% | |
| 1-Year Volatility | 30.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $2.29 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.72% | |
| Total Dividend | $1.51 | |
| $54.24M | ||
| 12.77% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.09B | |
| EPS | $2.04 | |
| Gross Profit | $1.29B | |
| Gross Margin | 61.79% | |
| Operating Profit | $520.31M | |
| Operating Margin | 24.90% | |
| Net Income | $424.88M | |
| Net Margin | 20.33% | |
| EBITDA | $714.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.44 | |
| 3.90 | ||
| 3.31 | ||
| - | ||
| 6 | ||
| 3.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 19.86 | |
| 4.00 | ||
| 2.21 | ||
| 12.47 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $3.78B | |
| $1.10B | ||
| $6.30B | ||
| $2.00B | ||
| $2.52B | ||
| $512.14M | ||
| Total Debt | $1.65B | |
| $0.00 | ||
| $72.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.67B | ||
| $771.19M | ||
| $798.50M | ||
| $0.00 | ||
| $193.75M | ||
| $0.00 | ||
| $65.39M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $654.33M | ||
| -$305.28M | ||
| -$178.98M | ||
| Capex | $207.13M | |
| $447.20M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Deutsche Bank | → | |
| Stifel | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Deutsche Bank | → | |
| Barclays | → | |
| Citigroup | → | |
| Barclays | → | |
| UBS | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with QGEN
FAQ
What is the ticker symbol for Qiagen N.V.?
The ticker symbol for Qiagen N.V. is NYSE:QGEN
Does Qiagen N.V. pay dividends?
Yes, Qiagen N.V. pays dividends. The last payment was $2.29, with an ex-dividend date on January 7, 2026
What sector is Qiagen N.V. in?
Qiagen N.V. is in the Healthcare sector
What industry is Qiagen N.V. in?
Qiagen N.V. is in the Diagnostics & Research industry
What country is Qiagen N.V. based in?
Qiagen N.V. is headquartered in Netherlands
When did Qiagen N.V. go public?
Qiagen N.V. initial public offering (IPO) was on June 28, 1996
Is Qiagen N.V. in the S&P 500?
No, Qiagen N.V. is not included in the S&P 500 index
Is Qiagen N.V. in the NASDAQ 100?
No, Qiagen N.V. is not included in the NASDAQ 100 index
Is Qiagen N.V. in the Dow Jones?
No, Qiagen N.V. is not included in the Dow Jones index
When was Qiagen N.V. last earnings report?
Qiagen N.V.'s most recent earnings report was on February 4, 2026
When does Qiagen N.V. report earnings?
The next expected earnings date for Qiagen N.V. is May 6, 2026
Data Sources & References
- QGEN Official Website www.qiagen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1015820/000101582026000003/0001015820-26-000003-index.htm
- QGEN Profile on Yahoo Finance finance.yahoo.com/quote/QGEN
- QGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/qgen